跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Oculat - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Oculat
Approved
STANDARD
Oculat
Remington Pharmaceutical industries (Pvt.) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
db3ad5e5c574709e
Company
Remington Pharmaceutical industries (Pvt.) Ltd.
Type
Standard
Approval Details
Approval Id
db3ad5e5c574709e
Drug Approval Philippines Name
Oculat
Product Name
Oculat
Registration Number
DRP-12204
Brand Name
Oculat
Generic Name
Latanoprost
Dosage Form
Ophthalmic Solution
Dosage Strength
50 mcg/mL
Manufacturer
Remington Pharmaceutical industries (Pvt.) Ltd.
Importer
Ophthamed Pharma Corp.
Distributor
Ophthamed Pharma Corp.
Issuance Date
25 August 2024
Expiry Date
26 January 2030
Pharmacologic Category
Anti-Glaucoma (Prostaglandin analogue)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
db3ad5e5c574709e
Type
Standard
Back to Philippines FDA Approvals